home / stock / siox / siox news


SIOX News and Press, Sio Gene Therapies Inc. From 05/07/21

Stock Information

Company Name: Sio Gene Therapies Inc.
Stock Symbol: SIOX
Market: NASDAQ
Website: siogtx.com

Menu

SIOX SIOX Quote SIOX Short SIOX News SIOX Articles SIOX Message Board
Get SIOX Alerts

News, Short Squeeze, Breakout and More Instantly...

SIOX - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Satu...

SIOX - 3 Penny Stocks To Buy On Robinhood With Biotech Catalysts In May 2021

Biotech Penny Stocks On Robinhood To Watch Right Now Penny stocks are in a bright spotlight heading into the month ahead. With Monday marking the first trading day of May, it’s important to take time, analyze trends and get ready for what the market has in store. But, whether you...

SIOX - Week 18 MDA Breakout Stocks - May 2021: Short-Term Picks To Give You An Edge

Two new breakout stocks for Week 18 with better than 10% short-term upside potential. This past week 1 of 4 stocks beat 10% in less than 5 days with ACET peaking at +16.2% closing up +14.6%. Two other stocks peaked at +8.7% and +6.3%. 2021 MDA minimal portfolio returns are -5.3% a...

SIOX - Bristol-Myers cut to neutral at Morgan Stanly noting an 'uninspired' pipeline, Community Health upgraded after Q1 results; and more in today's analyst action

Bristol-Myers and Community Health Systems have seen their rating changed after reporting two contrasting performances with their Q1 financials. Today’s analyst action also includes a few initiations.Bristol-Myers downgraded at Morgan Stanley; says uninspired by the pipelineBristo...

SIOX - Sio Gene Therapies Announces Four Upcoming Oral Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy

NEW YORK, and RESEARCH TRIANGLE PARK, N.C., April 28, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, today announced four upcoming or...

SIOX - Sio Gene Therapies to Participate in Upcoming Conferences

NEW YORK and RESEARCH TRIANGLE PARK, N.C., March 29, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically improve the lives of patients with neurodegenerative diseases, announced today that the company wi...

SIOX - Sio Gene CEO discloses insider buying

Sio Gene Therapies ([[SIOX]] +9.0%) has witnessed its first insider transaction for the year with the CEO Pavan Cheruvu disclosing the purchase of 100K company shares raising his total holdings at the company to ~180.4K shares.According to a regulatory filing submitted yesterday, Cheruvu...

SIOX - LITE, NBIX, CIDM and VIRX among premarket gainers

Pieris Pharmaceuticals PIRS +46% on collaboration with Seagen.Houston Wire & Cable Company HWCC +41% on being acquired by OmniCable for $5.30 per share.Cellect Biotechnology APOP +41% on a definitive merger agreement with Quoin Pharmaceuticals.Immutep Limited...

SIOX - Insurgent AI And Our Innovation Economy

Innovation, R&D and an aging population are long-term secular trends that will provide a tailwind to the biotechnology sector. The Insurgent AI Deep Innovation Model uses Deep Learning and secular tailwinds to generate alpha. Evaluating investment strategies is challenging, es...

SIOX - Sio Gene Therapies Provides Update on Cash Position and Major Upcoming GM1 Gangliosidosis Program Milestones

Company had $120.9 million of cash and cash equivalents as of March 12, 2021 Substantial increase in liquidity driven by equity investment from Suvretta Capital and sale of Arvelle shares Company estimates it is fully funded through major upcoming milestones for GM1 gene...

Previous 10 Next 10